BIO-RAD LABORATORIES, INC. acquires Celsee, Inc.
Snapshot
BIO-RAD LABORATORIES, INC. acquired Celsee, Inc. for $99.3 million total consideration, including fair value of contingent consideration of up to $60.0 million payable on certain 2021-2022 net-revenue achievement in April 2020. The transaction was structured as all cash plus contingent consideration. Celsee, Inc. is a Life Science business.
- Acquirer
- BIO-RAD LABORATORIES, INC.
- Target
- Celsee, Inc.
- Value
- $99.3 million total consideration, including fair value of contingent consideration of up to $60.0 million payable on certain 2021-2022 net-revenue achievement
- Date
- April 2020
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
BIO-RAD LABORATORIES, INC. acquired Celsee, Inc. for $99.3 million total consideration, including fair value of contingent consideration of up to $60.0 million payable on certain 2021-2022 net-revenue achievement, a transaction completed in April 2020, structured as all cash plus contingent consideration.
Celsee, Inc. operates in Life Science. Celsee is a manufacturer of instruments and consumables for the isolation, detection, and analysis of single cells.
We believe this acquisition will complement our Life Science product offerings.
Single-cell isolation and analysis platform adjacent to Bio-Rad's Life Science franchise. Complements Life Science product offerings. Life Science segment
No advisory firms have been disclosed for this transaction.